Literature DB >> 27072119

Reproductive, maternal, newborn, and child health: key messages from Disease Control Priorities 3rd Edition.

Robert E Black1, Carol Levin2, Neff Walker3, Doris Chou4, Li Liu5, Marleen Temmerman4.   

Abstract

As part of Disease Control Priorities 3rd Edition, the World Bank will publish a volume on Reproductive, Maternal, Newborn, and Child Health that identifies essential cost-effective health interventions that can be scaled up to reduce maternal, newborn, and child deaths, and stillbirths. This Review summarises the volume's key findings and estimates the effect and cost of expanded implementation of these interventions. Recognising that a continuum of care from the adolescent girl, woman, or mother to child is needed, the volume includes details of preventive and therapeutic health interventions in integrated packages: Maternal and Newborn Health and Child Health (along with folic acid supplementation, a key reproductive health intervention). Scaling up all interventions in these packages from coverage in 2015 to hypothetically immediately achieve 90% coverage would avert 149 000 maternal deaths, 849 000 stillbirths, 1 498 000 neonatal deaths, and 1 515 000 additional child deaths. In alternative calculations that consider only the effects of reducing the number of pregnancies by provision of contraceptive services as part of a Reproductive Health package, meeting 90% of the unmet need for contraception would reduce global births by almost 28 million and consequently avert deaths that could have occurred at 2015 rates of fertility and mortality. Thus, 67 000 maternal deaths, 440 000 neonatal deaths, 473 000 child deaths, and 564 000 stillbirths could be averted from avoided pregnancies. Particularly effective interventions in the Maternal and Newborn Health and Child Health packages would be management of labour and delivery, care of preterm births, and treatment of serious infectious diseases and acute malnutrition. Nearly all of these essential interventions can be delivered by health workers in the community or in primary health centres, which can increase population access to needed services. The annual incremental cost of immediately scaling up these essential interventions would be US$6·2 billion in low-income countries, $12·4 billion in lower-middle-income countries, and $8·0 billion in upper-middle-income countries. With the additional funding, greater focus on high-effect integrated interventions and innovations in service delivery, such as task shifting to other groups of health workers and supply and demand incentives, can help rectify major gaps in accessibility and quality of care. In recent decades, reduction of avoidable maternal and child deaths has been a global priority. With continued priority and expansion of essential reproductive, maternal, newborn, and child health interventions to high coverage, equity, and quality, as well as interventions to address underlying problems such as women's low status in society and violence against women, these deaths and substantial morbidity can be largely eliminated in another generation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27072119     DOI: 10.1016/S0140-6736(16)00738-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  85 in total

1.  Indigenous women's access to maternal healthcare services in lower- and middle-income countries: a systematic integrative review.

Authors:  Shahinoor Akter; Kate Davies; Jane Louise Rich; Kerry Jill Inder
Journal:  Int J Public Health       Date:  2018-11-30       Impact factor: 3.380

2.  Uptake and correlates of contraception among postpartum women in Kenya: results from a national cross-sectional survey.

Authors:  Dunstan Achwoka; Jillian Pintye; Christine J McGrath; John Kinuthia; Jennifer A Unger; Norah Obudho; Agnes Langat; Grace John-Stewart; Alison L Drake
Journal:  Contraception       Date:  2017-10-12       Impact factor: 3.375

3.  Epidemiological analysis of maternal deaths in Hunan province in China between 2009 and 2014.

Authors:  Xiong Lili; He Jian; Zeng Mengjun; Wu Yinglan; Xie Donghua; Wang Aihua; Kong Fanjuan; Wang Hua; Liu Zhiyu
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

4.  Assessment of Inventory Management Practice and Associated Challenges of Maternal, Newborn, and Child Health Life-Saving Drugs in Public Hospitals of Southwest Ethiopia: A Mixed-Method Approach.

Authors:  Azmeraw Bekele; Wondwosen Kumsa; Mihret Ayalew
Journal:  Integr Pharm Res Pract       Date:  2022-09-07

5.  Prevalence and risk factor for mistreatment in childbirth: In health facilities of Gondar city, Ethiopia.

Authors:  Dagmawit Shemelis; Abebaw Addis Gelagay; Moges Muluneh Boke
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

6.  Associates of Neonatal, Infant and Child Mortality in the Islamic Republic of Pakistan: A Multilevel Analysis Using the 2012-2013 Demographic and Health Surveys.

Authors:  Anna Helova; Kristine R Hearld; Henna Budhwani
Journal:  Matern Child Health J       Date:  2017-02

7.  Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

8.  Prediction of Birth Weight by Using Neonatal Anthropometric Parameters at Birth in Finote Selam Hospital, Ethiopia.

Authors:  Chalachew Tiruneh; Daniel Teshome
Journal:  Pediatric Health Med Ther       Date:  2021-06-01

9.  Magnitude and risk of neonatal death in neonatal intensive care unit at referral hospital in Godeo Zone: a prospective cohort study.

Authors:  Akine Eshete; Henok Tadesse; Tizalegn Tesfaye; Silesh Abiy
Journal:  Pan Afr Med J       Date:  2021-02-22

10.  The cost-effectiveness of community health workers delivering free diarrhoea treatment: evidence from Uganda.

Authors:  Zachary Wagner; Rushil Zutshi; John Bosco Asiimwe; David Levine
Journal:  Health Policy Plan       Date:  2022-01-13       Impact factor: 3.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.